Conference Reports for NATAP

5th IAS Conference on HIV Pathogenesis, Treatment and Prevention July 19th-22nd 2009 Capetown, South Africa Back

The MONET trial: darunavir/ritonavir monotherapy shows non-inferior efficacy to standard HAART, for patients with HIV RNA <50 copies/mL at baseline       JR Arribas, A Horban, J Gerstoft, G Fatkenheuer, M Nelson, N Clumeck, F Pulido, A Hill, Y van Delft, C Moecklinghoff, T Stark for the MONET Study Group   Oral Late-Breaker presentation at 5th IAS Conference Cape Town, South Africa, July 2009